Cancer News and Research

Latest Cancer News and Research

Research findings provide new avenues to target virus infection

Research findings provide new avenues to target virus infection

Novel biomarkers enhance power to predict therapeutic efficacy in LN prognostic models

Novel biomarkers enhance power to predict therapeutic efficacy in LN prognostic models

Novel microwave-induced photodynamic therapy could target deeply situated tumors

Novel microwave-induced photodynamic therapy could target deeply situated tumors

New image analysis technique helps better identify and distinguish between two cancer cell types

New image analysis technique helps better identify and distinguish between two cancer cell types

Financial difficulties may impact treatment outcomes for cancer patients

Financial difficulties may impact treatment outcomes for cancer patients

Botanical supplements may reduce effectiveness of common anti-tuberculosis drug, study finds

Botanical supplements may reduce effectiveness of common anti-tuberculosis drug, study finds

Sense Media launch MediSens: a highly-anticipated European medical imaging conference

Sense Media launch MediSens: a highly-anticipated European medical imaging conference

Dogs role in detecting disease shown to be supported by the public

Dogs role in detecting disease shown to be supported by the public

New review questions safety of estrogen replacement therapy

New review questions safety of estrogen replacement therapy

Researchers describe novel host-oriented therapeutic approach for preventing lethal immune responses

Researchers describe novel host-oriented therapeutic approach for preventing lethal immune responses

Study highlights burden, poor prognosis of head and neck cancers linked to tobacco/alcohol

Study highlights burden, poor prognosis of head and neck cancers linked to tobacco/alcohol

Survey finds seven out of ten cancer patients receive palliative care consultation at ESMO Designated Centres

Survey finds seven out of ten cancer patients receive palliative care consultation at ESMO Designated Centres

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

Brain atrophy patterns linked to loss of specific cognitive abilities in patients with Alzheimer's disease

Brain atrophy patterns linked to loss of specific cognitive abilities in patients with Alzheimer's disease

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

Study of pan-FGFR inhibitor uses mRNA in tumours to identify responders

Study of pan-FGFR inhibitor uses mRNA in tumours to identify responders

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

Immunotherapy redefines treatment approach for metastatic bladder cancer patients

Immunotherapy redefines treatment approach for metastatic bladder cancer patients

Kessler Foundation receives Spinal Cord Injury Model System Grant from NIDILRR

Kessler Foundation receives Spinal Cord Injury Model System Grant from NIDILRR

Common food-poisoning bacteria linked to increased risk of Crohn's disease

Common food-poisoning bacteria linked to increased risk of Crohn's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.